We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Scientists Succeed in Cloning a Cat

By Biotechdaily staff writers
Posted on 21 May 2002
In a forecast of what may turn out to be a popular use of cloning, scientists at Texas A&M University (College Station, USA) have successfully cloned a cat. More...
The research was published in the February 21, 2002, issue of Nature.

The cloned kitten, called cc ("carbon copy”), is about two months old and appears to be healthy. To clone the cat, the researchers took cells from adult female cats and placed them into cat eggs after removing the DNA in the eggs. The resulting 87 embryos were implanted in surrogate mothers. One surrogate, called Allie, produced cc. Although genetically identical, cc does not look like her mother. The researchers say this is because coat color in cats is only partly genetically determined. Initially, the research team had used cells from a male cat, but these failed to work.

The cloning was supported by Genetic Savings and Clone (also in College Station, TX), a commercial enterprise formed to offer cloning to dog and cat owners, although dogs have been found more difficult to clone than cats. Some experts believe that commercial reproduction of pets will be the first large-scale use of cloning. However, many people continue to voice opposition to cloning for reproduction. One such objection, following the announcement of cc's cloning, came in a statement from the Humane Society of the United States, which said that cloning pets serves no commercial purpose and contributes to the overpopulation of pets. In spite of opposition, the challenges of cloning are likely to continue to intrigue some scientists.




Related Links:
Texas A&M

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.